An Open Label Phase 3 Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008256/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
An evaluation of long term safety of repeat ALD403 doses in Chronic Migraine
提供机构：
Vivli
创建时间：
2022-07-15
